サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1757095

慢性腎臓病（CKD）治療薬の世界市場 2025年～2029年

Global Chronic Kidney Disease (CKD) Drugs Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 228 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.69円
慢性腎臓病（CKD）治療薬の世界市場 2025年～2029年
出版日: 2025年06月12日
発行: TechNavio
ページ情報: 英文 228 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

慢性腎臓病（CKD）治療薬市場は2024年～2029年に40億7,590万米ドル、予測期間中のCAGRは4.9%で成長すると予測されます。

当レポートでは、慢性腎臓病（CKD）治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。世界のCKD有病率の上昇、世界のヘルスケア支出の増加、CKDの早期発見・診断の必要性に対する意識の高まりが市場を牽引しています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比 4.7%
CAGR 4.9%
増分額 40億7,590万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間における慢性腎臓病（CKD）治療薬市場の成長を促進する主な要因の一つとして、CKD治療薬の承認件数の増加を挙げています。また、CKD治療における精密医療の採用への注目の高まりとCKD治療における技術革新は、市場の大きな需要につながるであろう。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024年～2029年

第5章 市場規模実績

  • 慢性腎臓病（CKD）治療薬の世界市場 2019年～2023年
  • 薬物クラス別セグメント分析 2019年～2023年
  • 投与経路別セグメント分析 2019年～2023年
  • 流通チャネル別セグメント分析 2019年～2023年
  • 地域別セグメント分析 2019年～2023年
  • 国別セグメント分析 2019年～2023年

第6章 定性分析

  • AIの影響：慢性腎臓病（CKD）治療薬の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：薬剤クラス別

  • 市場セグメント
  • 比較：薬剤クラス別
  • ESA：市場規模と予測 2024年～2029年
  • カルシウムチャネル遮断薬：市場規模と予測 2024年～2029年
  • リン酸結合剤：市場規模と予測 2024年～2029年
  • ACE阻害薬：市場規模と予測 2024年～2029年
  • その他：市場規模と予測 2024年～2029年
  • 市場機会：薬剤クラス別

第9章 市場セグメンテーション：投与経路別

  • 市場セグメント
  • 比較：投与経路別
  • 経口：市場規模と予測 2024年～2029年
  • 皮下：市場規模と予測 2024年～2029年
  • 静脈内：市場規模と予測 2024年～2029年
  • 市場機会：投与経路別

第10章 市場セグメンテーション：流通チャネル別

  • 市場セグメント
  • 比較：流通チャネル別
  • オフライン：市場規模と予測 2024年～2029年
  • オンライン：市場規模と予測 2024年～2029年
  • 市場機会：流通チャネル別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 2024年～2029年
  • 欧州：市場規模と予測 2024年～2029年
  • アジア：市場規模と予測 2024年～2029年
  • 世界のその他の地域：市場規模と予測 2024年～2029年
  • 米国：市場規模と予測 2024年～2029年
  • 中国：市場規模と予測 2024年～2029年
  • ドイツ：市場規模と予測 2024年～2029年
  • インド：市場規模と予測 2024年～2029年
  • 英国：市場規模と予測 2024年～2029年
  • カナダ：市場規模と予測 2024年～2029年
  • フランス：市場規模と予測 2024年～2029年
  • 日本：市場規模と予測 2024年～2029年
  • ブラジル：市場規模と予測 2024年～2029年
  • 韓国：市場規模と予測 2024年～2029年
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Horizon Therapeutics Plc
  • Johnson and Johnson Services Inc.
  • Novartis AG
  • OPKO Health Inc.
  • Pfizer Inc.
  • Sanofi SA

第16章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Chronic Kidney Disease (CKD) Drugs Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Drug Class - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Drug Class - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Drug Class
  • Exhibits41: Data Table on Comparison by Drug Class
  • Exhibits42: Chart on ESA - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on ESA - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on ESA - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on ESA - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Calcium channel blockers - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Calcium channel blockers - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Calcium channel blockers - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Calcium channel blockers - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on Phosphate binders - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on Phosphate binders - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on Phosphate binders - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on Phosphate binders - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Chart on ACE inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits55: Data Table on ACE inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits56: Chart on ACE inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits57: Data Table on ACE inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits62: Market opportunity by Drug Class ($ million)
  • Exhibits63: Data Table on Market opportunity by Drug Class ($ million)
  • Exhibits64: Chart on Route of Administration - Market share 2024-2029 (%)
  • Exhibits65: Data Table on Route of Administration - Market share 2024-2029 (%)
  • Exhibits66: Chart on Comparison by Route of Administration
  • Exhibits67: Data Table on Comparison by Route of Administration
  • Exhibits68: Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
  • Exhibits73: Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
  • Exhibits74: Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
  • Exhibits75: Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
  • Exhibits76: Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
  • Exhibits77: Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
  • Exhibits78: Chart on Intravenous - Year-over-year growth 2024-2029 (%)
  • Exhibits79: Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
  • Exhibits80: Market opportunity by Route of Administration ($ million)
  • Exhibits81: Data Table on Market opportunity by Route of Administration ($ million)
  • Exhibits82: Chart on Distribution Channel - Market share 2024-2029 (%)
  • Exhibits83: Data Table on Distribution Channel - Market share 2024-2029 (%)
  • Exhibits84: Chart on Comparison by Distribution Channel
  • Exhibits85: Data Table on Comparison by Distribution Channel
  • Exhibits86: Chart on Offline - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Offline - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Offline - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Offline - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Chart on Online - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Data Table on Online - Market size and forecast 2024-2029 ($ million)
  • Exhibits92: Chart on Online - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Data Table on Online - Year-over-year growth 2024-2029 (%)
  • Exhibits94: Market opportunity by Distribution Channel ($ million)
  • Exhibits95: Data Table on Market opportunity by Distribution Channel ($ million)
  • Exhibits96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits97: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits99: Chart on Geographic comparison
  • Exhibits100: Data Table on Geographic comparison
  • Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Market opportunity By Geographical Landscape ($ million)
  • Exhibits158: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits159: Impact of drivers and challenges in 2024 and 2029
  • Exhibits160: Overview on criticality of inputs and factors of differentiation
  • Exhibits161: Overview on factors of disruption
  • Exhibits162: Impact of key risks on business
  • Exhibits163: Companies covered
  • Exhibits164: Company ranking index
  • Exhibits165: Matrix on companies position and classification
  • Exhibits166: Abbott Laboratories - Overview
  • Exhibits167: Abbott Laboratories - Business segments
  • Exhibits168: Abbott Laboratories - Key news
  • Exhibits169: Abbott Laboratories - Key offerings
  • Exhibits170: Abbott Laboratories - Segment focus
  • Exhibits171: SWOT
  • Exhibits172: AbbVie Inc. - Overview
  • Exhibits173: AbbVie Inc. - Product / Service
  • Exhibits174: AbbVie Inc. - Key news
  • Exhibits175: AbbVie Inc. - Key offerings
  • Exhibits176: SWOT
  • Exhibits177: Amgen Inc. - Overview
  • Exhibits178: Amgen Inc. - Product / Service
  • Exhibits179: Amgen Inc. - Key news
  • Exhibits180: Amgen Inc. - Key offerings
  • Exhibits181: SWOT
  • Exhibits182: AstraZeneca Plc - Overview
  • Exhibits183: AstraZeneca Plc - Product / Service
  • Exhibits184: AstraZeneca Plc - Key news
  • Exhibits185: AstraZeneca Plc - Key offerings
  • Exhibits186: SWOT
  • Exhibits187: Bayer AG - Overview
  • Exhibits188: Bayer AG - Business segments
  • Exhibits189: Bayer AG - Key news
  • Exhibits190: Bayer AG - Key offerings
  • Exhibits191: Bayer AG - Segment focus
  • Exhibits192: SWOT
  • Exhibits193: Biogen Inc. - Overview
  • Exhibits194: Biogen Inc. - Product / Service
  • Exhibits195: Biogen Inc. - Key offerings
  • Exhibits196: SWOT
  • Exhibits197: Boehringer Ingelheim International GmbH - Overview
  • Exhibits198: Boehringer Ingelheim International GmbH - Product / Service
  • Exhibits199: Boehringer Ingelheim International GmbH - Key news
  • Exhibits200: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits201: SWOT
  • Exhibits202: Eli Lilly and Co. - Overview
  • Exhibits203: Eli Lilly and Co. - Product / Service
  • Exhibits204: Eli Lilly and Co. - Key offerings
  • Exhibits205: SWOT
  • Exhibits206: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits207: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits208: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits209: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits210: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits211: SWOT
  • Exhibits212: Horizon Therapeutics Plc - Overview
  • Exhibits213: Horizon Therapeutics Plc - Product / Service
  • Exhibits214: Horizon Therapeutics Plc - Key offerings
  • Exhibits215: SWOT
  • Exhibits216: Johnson and Johnson Services Inc. - Overview
  • Exhibits217: Johnson and Johnson Services Inc. - Business segments
  • Exhibits218: Johnson and Johnson Services Inc. - Key news
  • Exhibits219: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits220: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits221: SWOT
  • Exhibits222: Novartis AG - Overview
  • Exhibits223: Novartis AG - Business segments
  • Exhibits224: Novartis AG - Key news
  • Exhibits225: Novartis AG - Key offerings
  • Exhibits226: Novartis AG - Segment focus
  • Exhibits227: SWOT
  • Exhibits228: OPKO Health Inc. - Overview
  • Exhibits229: OPKO Health Inc. - Business segments
  • Exhibits230: OPKO Health Inc. - Key offerings
  • Exhibits231: OPKO Health Inc. - Segment focus
  • Exhibits232: SWOT
  • Exhibits233: Pfizer Inc. - Overview
  • Exhibits234: Pfizer Inc. - Product / Service
  • Exhibits235: Pfizer Inc. - Key news
  • Exhibits236: Pfizer Inc. - Key offerings
  • Exhibits237: SWOT
  • Exhibits238: Sanofi SA - Overview
  • Exhibits239: Sanofi SA - Business segments
  • Exhibits240: Sanofi SA - Key news
  • Exhibits241: Sanofi SA - Key offerings
  • Exhibits242: Sanofi SA - Segment focus
  • Exhibits243: SWOT
  • Exhibits244: Inclusions checklist
  • Exhibits245: Exclusions checklist
  • Exhibits246: Currency conversion rates for US$
  • Exhibits247: Research methodology
  • Exhibits248: Information sources
  • Exhibits249: Data validation
  • Exhibits250: Validation techniques employed for market sizing
  • Exhibits251: Data synthesis
  • Exhibits252: 360 degree market analysis
  • Exhibits253: List of abbreviations
目次
Product Code: IRTNTR76853

The chronic kidney disease (CKD) drugs market is forecasted to grow by USD 4,075.9 mn during 2024-2029, accelerating at a CAGR of 4.9% during the forecast period. The report on the chronic kidney disease (CKD) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of ckd globally, increase in healthcare expenditure globally, and growing awareness about need for early detection and diagnosis of ckd.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20254.7%
CAGR4.9%
Incremental Value$4,075.9 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's chronic kidney disease (CKD) drugs market is segmented as below:

By Drug Class

    • Erythropoietin stimulating agents
    • Calcium channel blockers
    • Phosphate binders
    • ACE inhibitors
    • Others

By Route Of Administration

    • Oral
    • Subcutaneous
    • Intravenous

By Distribution Channel

    • Offline
    • Online

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the growing number of drug approvals for ckd treatment as one of the prime reasons driving the chronic kidney disease (CKD) drugs market growth during the next few years. Also, rising focus on adoption of precision medicine for ckd treatment and technological innovations in ckd treatment will lead to sizable demand in the market.

The report on the chronic kidney disease (CKD) drugs market covers the following areas:

    • Chronic Kidney Disease (CKD) Drugs Market sizing
    • Chronic Kidney Disease (CKD) Drugs Market forecast
    • Chronic Kidney Disease (CKD) Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic kidney disease (CKD) drugs market vendors that include Abbott Laboratories, AbbVie Inc., Akebia Therapeutics, Amgen Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Horizon Therapeutics Plc, Johnson and Johnson Services Inc., Novartis AG, OPKO Health Inc., Pfizer Inc., Rockwell Medical Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Zydus Lifesciences Ltd.. Also, the chronic kidney disease (CKD) drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Drug Class
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Market Segmentation by Distribution Channel
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Chronic Kidney Disease (CKD) Drugs Market 2019 - 2023
    • Historic Market Size - Data Table on Global Chronic Kidney Disease (CKD) Drugs Market 2019 - 2023 ($ million)
  • 5.2 Drug Class segment analysis 2019 - 2023
    • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • 5.3 Route of Administration segment analysis 2019 - 2023
    • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • 5.4 Distribution Channel segment analysis 2019 - 2023
    • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on global chronic kidney disease (CKD) drugs market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Drug Class

  • 8.1 Market segments
    • Chart on Drug Class - Market share 2024-2029 (%)
    • Data Table on Drug Class - Market share 2024-2029 (%)
  • 8.2 Comparison by Drug Class
    • Chart on Comparison by Drug Class
    • Data Table on Comparison by Drug Class
  • 8.3 ESA - Market size and forecast 2024-2029
    • Chart on ESA - Market size and forecast 2024-2029 ($ million)
    • Data Table on ESA - Market size and forecast 2024-2029 ($ million)
    • Chart on ESA - Year-over-year growth 2024-2029 (%)
    • Data Table on ESA - Year-over-year growth 2024-2029 (%)
  • 8.4 Calcium channel blockers - Market size and forecast 2024-2029
    • Chart on Calcium channel blockers - Market size and forecast 2024-2029 ($ million)
    • Data Table on Calcium channel blockers - Market size and forecast 2024-2029 ($ million)
    • Chart on Calcium channel blockers - Year-over-year growth 2024-2029 (%)
    • Data Table on Calcium channel blockers - Year-over-year growth 2024-2029 (%)
  • 8.5 Phosphate binders - Market size and forecast 2024-2029
    • Chart on Phosphate binders - Market size and forecast 2024-2029 ($ million)
    • Data Table on Phosphate binders - Market size and forecast 2024-2029 ($ million)
    • Chart on Phosphate binders - Year-over-year growth 2024-2029 (%)
    • Data Table on Phosphate binders - Year-over-year growth 2024-2029 (%)
  • 8.6 ACE inhibitors - Market size and forecast 2024-2029
    • Chart on ACE inhibitors - Market size and forecast 2024-2029 ($ million)
    • Data Table on ACE inhibitors - Market size and forecast 2024-2029 ($ million)
    • Chart on ACE inhibitors - Year-over-year growth 2024-2029 (%)
    • Data Table on ACE inhibitors - Year-over-year growth 2024-2029 (%)
  • 8.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.8 Market opportunity by Drug Class
    • Market opportunity by Drug Class ($ million)
    • Data Table on Market opportunity by Drug Class ($ million)

9 Market Segmentation by Route of Administration

  • 9.1 Market segments
    • Chart on Route of Administration - Market share 2024-2029 (%)
    • Data Table on Route of Administration - Market share 2024-2029 (%)
  • 9.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 9.3 Oral - Market size and forecast 2024-2029
    • Chart on Oral - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
    • Chart on Oral - Year-over-year growth 2024-2029 (%)
    • Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • 9.4 Subcutaneous - Market size and forecast 2024-2029
    • Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
    • Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
    • Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
    • Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
  • 9.5 Intravenous - Market size and forecast 2024-2029
    • Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
    • Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
    • Chart on Intravenous - Year-over-year growth 2024-2029 (%)
    • Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ million)
    • Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by Distribution Channel

  • 10.1 Market segments
    • Chart on Distribution Channel - Market share 2024-2029 (%)
    • Data Table on Distribution Channel - Market share 2024-2029 (%)
  • 10.2 Comparison by Distribution Channel
    • Chart on Comparison by Distribution Channel
    • Data Table on Comparison by Distribution Channel
  • 10.3 Offline - Market size and forecast 2024-2029
    • Chart on Offline - Market size and forecast 2024-2029 ($ million)
    • Data Table on Offline - Market size and forecast 2024-2029 ($ million)
    • Chart on Offline - Year-over-year growth 2024-2029 (%)
    • Data Table on Offline - Year-over-year growth 2024-2029 (%)
  • 10.4 Online - Market size and forecast 2024-2029
    • Chart on Online - Market size and forecast 2024-2029 ($ million)
    • Data Table on Online - Market size and forecast 2024-2029 ($ million)
    • Chart on Online - Year-over-year growth 2024-2029 (%)
    • Data Table on Online - Year-over-year growth 2024-2029 (%)
  • 10.5 Market opportunity by Distribution Channel
    • Market opportunity by Distribution Channel ($ million)
    • Data Table on Market opportunity by Distribution Channel ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.9 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.10 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.11 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.12 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.13 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.14 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.15 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.16 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 15.5 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 15.6 Amgen Inc.
    • Amgen Inc. - Overview
    • Amgen Inc. - Product / Service
    • Amgen Inc. - Key news
    • Amgen Inc. - Key offerings
    • SWOT
  • 15.7 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 15.8 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 15.9 Biogen Inc.
    • Biogen Inc. - Overview
    • Biogen Inc. - Product / Service
    • Biogen Inc. - Key offerings
    • SWOT
  • 15.10 Boehringer Ingelheim International GmbH
    • Boehringer Ingelheim International GmbH - Overview
    • Boehringer Ingelheim International GmbH - Product / Service
    • Boehringer Ingelheim International GmbH - Key news
    • Boehringer Ingelheim International GmbH - Key offerings
    • SWOT
  • 15.11 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 15.12 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.13 Horizon Therapeutics Plc
    • Horizon Therapeutics Plc - Overview
    • Horizon Therapeutics Plc - Product / Service
    • Horizon Therapeutics Plc - Key offerings
    • SWOT
  • 15.14 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
    • SWOT
  • 15.15 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 15.16 OPKO Health Inc.
    • OPKO Health Inc. - Overview
    • OPKO Health Inc. - Business segments
    • OPKO Health Inc. - Key offerings
    • OPKO Health Inc. - Segment focus
    • SWOT
  • 15.17 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.18 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations